injectable – Health

Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa

A cost-effectiveness analysis has found that injectable, long-lasting antiretroviral therapy (ART) would need to cost no more than $ 131 a year in order to be cost-effective if used for patients who are not fully virally suppressed in lower-income settings in regions like sub-Saharan Africa. The analysis found that injectable cabotegravir/rilpivirine would only reach the… Read More »

Glaxo's ViiV touts more two-drug HIV success with monthly injectable win

GlaxoSmithKline’s ViiV Healthcare has already shown that a two-drug HIV regimen can hang with its three-drug competitors. But now it has data showing it can do the same with administration just once per month. Thursday, ViiV rolled out results from two studies showing an injection pairing its own cabotegravir with Johnson & Johnson’s rilpivirine (Edurant), given once every four… Read More »